396 related articles for article (PubMed ID: 30182253)
21. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors.
Wan Y; Hao H; Meng S; Li Z; Yu F; Meng Chi ; Chao Q; Gao J
Pancreatology; 2021 Jan; 21(1):240-245. PubMed ID: 33191144
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors.
Fujimori N; Osoegawa T; Lee L; Tachibana Y; Aso A; Kubo H; Kawabe K; Igarashi H; Nakamura K; Oda Y; Ito T
Scand J Gastroenterol; 2016; 51(2):245-52. PubMed ID: 26513346
[TBL] [Abstract][Full Text] [Related]
23. Machine Learning Methods Based on CT Features Differentiate G1/G2 From G3 Pancreatic Neuroendocrine Tumors.
Chen HY; Pan Y; Chen JY; Chen J; Liu LL; Yang YB; Li K; Ma Q; Shi L; Yu RS; Shao GL
Acad Radiol; 2024 May; 31(5):1898-1905. PubMed ID: 38052672
[TBL] [Abstract][Full Text] [Related]
24. Grade 3 Pancreatic Neuroendocrine Tumors on MDCT: Establishing a Diagnostic Model and Comparing Survival Against Pancreatic Ductal Adenocarcinoma.
Chen HY; Zhang XY; Deng XY; Ge YL; Tang YQ; Cui H; Yang B; Pan Y; Shi D; Yu RS
AJR Am J Roentgenol; 2020 Aug; 215(2):390-397. PubMed ID: 32432906
[No Abstract] [Full Text] [Related]
25. Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology.
Zamboni GA; Ambrosetti MC; Zivelonghi C; Lombardo F; Butturini G; Cingarlini S; Capelli P; Pozzi Mucelli R
HPB (Oxford); 2017 Nov; 19(11):986-991. PubMed ID: 28784262
[TBL] [Abstract][Full Text] [Related]
26. Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade.
Kim JH; Eun HW; Kim YJ; Han JK; Choi BI
Abdom Imaging; 2013 Oct; 38(5):1106-14. PubMed ID: 23728305
[TBL] [Abstract][Full Text] [Related]
27. Complementary role of computed tomography texture analysis for differentiation of pancreatic ductal adenocarcinoma from pancreatic neuroendocrine tumors in the portal-venous enhancement phase.
Reinert CP; Baumgartner K; Hepp T; Bitzer M; Horger M
Abdom Radiol (NY); 2020 Mar; 45(3):750-758. PubMed ID: 31953587
[TBL] [Abstract][Full Text] [Related]
28. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.
Guo C; Zhuge X; Wang Q; Xiao W; Wang Z; Wang Z; Feng Z; Chen X
Cancer Imaging; 2018 Oct; 18(1):37. PubMed ID: 30333055
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic neuroendocrine neoplasms: Correlation between MR features and pathological tumor grades.
Jin F; Wang K; Qin TT; Li X; Guo F; Ma GN; Hu XH; Han P
J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):587-595. PubMed ID: 28786064
[TBL] [Abstract][Full Text] [Related]
30. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features.
van der Pol CB; Lee S; Tsai S; Larocque N; Alayed A; Williams P; Schieda N
Abdom Radiol (NY); 2019 Mar; 44(3):992-999. PubMed ID: 30603880
[TBL] [Abstract][Full Text] [Related]
32. Prediction of the World Health Organization Grade of rectal neuroendocrine tumors based on CT histogram analysis.
Liang P; Xu C; Tan F; Li S; Chen M; Hu D; Kamel I; Duan Y; Li Z
Cancer Med; 2021 Jan; 10(2):595-604. PubMed ID: 33263225
[TBL] [Abstract][Full Text] [Related]
33. Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging.
Lotfalizadeh E; Ronot M; Wagner M; Cros J; Couvelard A; Vullierme MP; Allaham W; Hentic O; Ruzniewski P; Vilgrain V
Eur Radiol; 2017 Apr; 27(4):1748-1759. PubMed ID: 27543074
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic neuroendocrine neoplasms at magnetic resonance imaging: comparison between grade 3 and grade 1/2 tumors.
Guo C; Chen X; Xiao W; Wang Q; Sun K; Wang Z
Onco Targets Ther; 2017; 10():1465-1474. PubMed ID: 28331340
[TBL] [Abstract][Full Text] [Related]
35. Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage.
De Robertis R; Cingarlini S; Tinazzi Martini P; Ortolani S; Butturini G; Landoni L; Regi P; Girelli R; Capelli P; Gobbo S; Tortora G; Scarpa A; Pederzoli P; D'Onofrio M
World J Gastroenterol; 2017 Jan; 23(2):275-285. PubMed ID: 28127201
[TBL] [Abstract][Full Text] [Related]
36. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
[TBL] [Abstract][Full Text] [Related]
37. Preoperative Identification of a Prognostic Factor for Pancreatic Neuroendocrine Tumors Using Multiphase Contrast-Enhanced Computed Tomography.
Yamada S; Fujii T; Suzuki K; Inokawa Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
Pancreas; 2016 Feb; 45(2):198-203. PubMed ID: 26390421
[TBL] [Abstract][Full Text] [Related]
38. Contrast-Enhanced Ultrasonography Findings Correlate with Pathologic Grades of Pancreatic Neuroendocrine Tumors.
Huang J; Chen J; Xu M; Zheng Y; Lin M; Huang G; Xie X; Xie X
Ultrasound Med Biol; 2021 Aug; 47(8):2097-2106. PubMed ID: 33934943
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
[TBL] [Abstract][Full Text] [Related]
40. Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication.
Kang TW; Kim SH; Lee J; Kim AY; Jang KM; Choi D; Kim MJ
Eur J Radiol; 2015 Nov; 84(11):2089-96. PubMed ID: 26318820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]